4//SEC Filing
Daniel Thomas O 4
Accession 0000899243-18-018338
CIK 0001690585other
Filed
Jun 26, 8:00 PM ET
Accepted
Jun 27, 4:34 PM ET
Size
9.2 KB
Accession
0000899243-18-018338
Insider Transaction Report
Form 4
Daniel Thomas O
Director
Transactions
- Conversion
Series B Preferred Stock
2018-06-25−30,028→ 0 total→ Common Stock (11,620 underlying) - Conversion
Common Stock
2018-06-25+24,527→ 101,926 total - Conversion
Series A Preferred Stock
2018-06-25−33,350→ 0 total→ Common Stock (12,907 underlying)
Footnotes (1)
- [F1]The Series A Preferred Stock and Series B Preferred Stock (collectively, the "Preferred Stock") converted into Common Stock on a 2.58398:1 basis upon the closing of the Issuer's initial public offering on June 25, 2018. The Preferred Stock had no expiration date.
Documents
Issuer
Magenta Therapeutics, Inc.
CIK 0001690585
Entity typeother
Related Parties
1- filerCIK 0001538894
Filing Metadata
- Form type
- 4
- Filed
- Jun 26, 8:00 PM ET
- Accepted
- Jun 27, 4:34 PM ET
- Size
- 9.2 KB